1. Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study. Issue 6 (8th March 2012) Authors: Emery, Paul; Kvien, Tore K; Combe, Bernard; Freundlich, Bruce; Robertson, Deborah; Ferdousi, Tahmina; Bananis, Eustratios; Pedersen, Ronald; Koenig, Andrew S Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 6(2012) Page Start: 989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable. Issue 1 (30th January 2017) Authors: Fleischmann, Roy M; van der Heijde, Désirée; Gardiner, Philip V; Szumski, Annette; Marshall, Lisa; Bananis, Eustratios Journal: RMD open Issue: Volume 3:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3. (December 2022) Authors: Rugo, Hope S.; Im, Seock-Ah; Joy, Anil A.; Shparyk, Yaroslav; Walshe, Janice M.; Sleckman, Bethany; Loi, Sherene; Theall, Kathy Puyana; Kim, Sindy; Huang, Xin; Bananis, Eustratios; Mahtani, Reshma; Finn, Richard S.; Diéras, Véronique Journal: Breast Issue: Volume 66(2022) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2. (October 2021) Authors: Gelmon, Karen; Walshe, Janice M.; Mahtani, Reshma; Joy, Anil A.; Karuturi, Meghan; Neven, Patrick; Lu, Dongrui Ray; Kim, Sindy; Schnell, Patrick; Bananis, Eustratios; Schwartzberg, Lee Journal: Breast Issue: Volume 59(2021) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer. Issue 3 (25th August 2019) Authors: Gelmon, Karen A.; Cristofanilli, Massimo; Rugo, Hope S.; DeMichele, Angela M.; Joy, Anil A.; Castrellon, Aurelio; Sleckman, Bethany; Mori, Ave; Theall, Kathy Puyana; Lu, Dongrui R.; Huang, Xin; Bananis, Eustratios; Finn, Richard S.; Slamon, Dennis J. Journal: Breast journal Issue: Volume 26:Issue 3(2020) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs. Issue 7 (14th August 2015) Authors: Charles-Schoeman, Christina; Burmester, Gerd; Nash, Peter; Zerbini, Cristiano A F; Soma, Koshika; Kwok, Kenneth; Hendrikx, Thijs; Bananis, Eustratios; Fleischmann, Roy Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 7(2016) Page Start: 1293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacyand Safety of Palbociclib (PAL) PUS Fulvestrant (F) by Geographic Region in Women with Endocrine-Resistant Hormone Receptor-Positive (HR+), Human Epiderman Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) from Paloma-3. (November 2017) Authors: Harbeck, Nadia; Colleoni, Marco; Demichele, Angela; Turner, Nicholas C.; Cristofanilli, Massimo; Verma, Shailendra; Sleckman, Bethany; Huang, Xin; Theall, Kathy Puyana; Bananis, Eustratios; Masuda, Norikazu; Im, Seock-Ah Journal: Breast Issue: Volume 36(2017) Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia. (October 2014) Authors: Pavelka, Karel; Burgos-Vargas, Ruben; Miranda, Pedro; Guzman, Renato; Yen, Jeng-Hsien; Izzi, Mustafa Al; Szekanecz, Zoltan; Tang, Boxiong; Szumski, Annette; Kotak, Sameer; Bananis, Eustratios; Koenig, Andrew S; Mahgoub, Ehab Y; Rahman, Mahboob U Journal: International journal of clinical rheumatology Issue: Volume 9:Number 5(2014) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. Issue 10 (6th September 2017) Authors: Winthrop, Kevin L.; Curtis, Jeffrey R.; Lindsey, Stephen; Tanaka, Yoshiya; Yamaoka, Kunihiro; Valdez, Hernan; Hirose, Tomohiro; Nduaka, Chudy I.; Wang, Lisy; Mendelsohn, Alan M.; Fan, Haiyun; Chen, Connie; Bananis, Eustratios Journal: Arthritis & rheumatology Issue: Volume 69:Issue 10(2017) Page Start: 1960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?. Issue 6 (20th August 2014) Authors: Fleischmann, Roy; van der Heijde, Désirée; Koenig, Andrew S; Pedersen, Ronald; Szumski, Annette; Marshall, Lisa; Bananis, Eustratios Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 6(2015) Page Start: 1132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗